Status
Ongoing
CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit
Status
Ongoing
Classification
Class II
Report Date
April 23, 2025
Termination Date
—